TITLE

Financings Roundup

PUB. DATE
May 2013
SOURCE
BioWorld Today;5/13/2013, Vol. 24 Issue 91, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers news briefs on financing of biotechnology companies in May 2013 including Discovery Laboratories Inc. of Warrington, Pennsylvania iCo Therapeutics Inc. of Vancouver, British Columbia and Omeros Corp. of Seattle, Washington.
ACCESSION #
87593104

 

Related Articles

  • Other News To Note.  // BioWorld Today;6/1/2012, Vol. 23 Issue 106, p2 

    This section offers news briefs on the biopharmaceutical industry. iCo Therapeutics Inc. received a 1.1 million dollar nonrepayable financial contribution from the National Research Council of Canada to support its oral Amphotericin B delivery system. Medigene AG's genital warts treatment...

  • Other News To Note.  // BioWorld Today;10/7/2013, Vol. 24 Issue 192, p2 

    This section offers news briefs on the biotechnology industry as of October 2013. Biota Pharmaceuticals Inc. is being investigated by Faruqi & Faruqi LLP for the board's possible breaches of fiduciary duties. The U.S. Food and Drug Administration (FDA) agreed to updated product specifications...

  • Week in Review.  // BioWorld Insight;7/16/2012, Vol. 20 Issue 29, p5 

    The article offers biotechnology industries news brief as of July 2012 on topics including money raised by PsiOxus Therapeutics Ltd., termination of drug trial by Merck & Co. Inc. and filing for bankruptcy liquidation by Biolex Therapeutics Inc.

  • Other News To Note.  // BioWorld Today;2/14/2012, Vol. 23 Issue 21, p7 

    This section offers news briefs on the biotechnology industry, including the fourth milestone payment received by Medicago Inc. from the Defense Advanced Research Projects Agency, the license agreement signed by OncoPep Inc. with the Dana-Farber Institute for a multipeptide therapeutic cancer...

  • Clinic Roundup.  // BioWorld Today;2/14/2012, Vol. 23 Issue 21, p7 

    This section offers news briefs on the biotechnology industry, including the initiation of a Phase II trial of TL-118 for pancreatic cancer by Tiltan Pharma Ltd., the start of a Phase I trial of TRV130 for the treatment of postoperative pain by Trevena Inc. and the preliminary results of the...

  • Financings Roundup.  // BioWorld Today;2/14/2012, Vol. 23 Issue 21, p8 

    This section offers news briefs on the biotechnology industry, including the 5 million dollars raised by Cardium Therapeutics Inc. via a registered direct offering of 17.9 million shares, the completion of an initial public offering by ChemoCentryx Inc. and the decision of the underwriters of...

  • Financings Roundup.  // BioWorld Today;2/22/2012, Vol. 23 Issue 35, p3 

    This section offers news briefs on the biotechnology industry, including the 15 million dollars in venture debt financing obtained by Ceptaris Therapeutics Inc. and the aim of Marshall Edwards Inc. to raise 8 million dollars via a rights offering to existing shareholders.

  • Clinic Roundup.  // BioWorld Today;3/22/2012, Vol. 23 Issue 46, p5 

    This section offers news briefs on the biopharmaceutical industry, including the release of data showing a trial testing of dipraglurant, a small-molecule allosteric modulator, by Addex Therapeutics SA, the completion of the first human trial of an H1N1 influenza vaccine (HAC1) by iBio Inc. and...

  • Pharma: Other News To Note.  // BioWorld Today;4/24/2012, Vol. 23 Issue 79, p7 

    This section offers news briefs on the biotechnology industry, including the selection of Biostar Pharmaceuticals Inc. to supply Huanghangning tablets for the treatment of cardiovascular disease, the decision of Pfizer Inc. to divest its nutrition business to Nestle and the acquisition of 49...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics